EverSlim review
The monthly figure covers the medication, the provider visit and the shipping, and it does not move as the dose does.
The verdict
EverSlim prices compounded semaglutide at a flat $113 a month and compounded tirzepatide at a flat $136, with the provider visit and shipping described as included in both. It covers fifty states and the District of Columbia.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 51
- From
- $113/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
EverSlim sells compounded semaglutide and compounded tirzepatide as weekly injections, reaching fifty states and the District of Columbia, and its two figures were $113 and $136 a month. Both are described as flat monthly prices, and both are stated to include the medication, the provider visit and shipping. The tirzepatide product is described by its mechanism, as a dual GLP-1 and GIP agonist.
Who writes the prescription, and what do they see?
A provider visit sits inside the monthly figure rather than beside it, which is the arrangement that makes a comparison with a cheaper headline elsewhere worth doing carefully. A seller charging $99 and billing a consultation separately can cost more across a year than one charging $113 with the visit inside. How often that visit repeats across a course of treatment is not something the priced row establishes.
Treatment is arranged remotely and the medication arrives by mail on a monthly rhythm, which is the plain version of this category rather than a point of difference. What is different is how little the reader has to keep track of: one charge, one date, and no second line for a visit or for postage. The $23 gap between the two molecules is narrow enough that a clinician's choice between them is unlikely to be made on price.
What happens when the dose goes up?
Both rates are described as flat monthly prices, so the escalation across the first sixteen weeks does not change the charge. That is the part of a course of treatment where a bill most often surprises a reader, and it is the part this seller has taken off the table. What the included visit covers at a dose change, and whether a change requires one, is not published beside the price.
What the price includes
$113 and $136 are low figures for a product with a visit and shipping folded into them, and the honest comparison is against an all-in figure elsewhere rather than against a medication-only headline. Nothing beside either figure was recorded as a separate charge. No prepay ladder is published, so a reader is not being asked to buy a year to reach the rate on the page.
What it claims, and what it cites
Both molecules are compounded, so a pharmacy prepares them and no regulator reviews the finished vial before it ships. Describing tirzepatide as a dual GLP-1 and GIP agonist is accurate — that is what the molecule is, and it is why it is priced above semaglutide almost everywhere. The published results for both came from the approved products at label doses, and a compounded preparation was not what those trials studied.
Where it holds up, and where it does not
- Strength: Provider visit and shipping included
- Strength: Rate flat at every dose
- Strength: One monthly charge, no prepay ladder
- Limitation: Visit frequency not published
- Limitation: Compounding pharmacy not named
- Limitation: No lower rung for a longer commitment
What the evidence says about this kind of treatment
The assessment above is about EverSlim. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants one monthly charge covering the medication, the visit and the postage, without a prepay term attached to reach the rate.
- Wrong for
- A reader who wants to know who compounds the vial, since the facility is not named beside either figure.
How EverSlim compares
| Seller | Who it suits | Go |
|---|---|---|
| Harper Meds | A reader who wants a clinician, a prescription and the medication under one charge, with no term to commit to before reaching the published rate. | See Harper Meds → |
 Liberty | A reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing. | See Liberty → |
| NextMeds | A reader who wants one charge covering medication and care, and who treats a rate running under a countdown timer as an intro rather than a standing price. | See NextMeds → |
More GLP-1 telehealth sellers reviews: PlushCarePreventiveMDRevel HealthTrimi HealthWholesome ClinicZera Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What does the monthly figure cover?
- The medication, the provider visit and shipping are all described as included at both $113 and $136. No separate consultation or postage charge was recorded beside either figure on August 15, 2026.
- Does the price rise with the dose?
- Both rates are described as flat monthly prices, so an escalation through the first sixteen weeks leaves the charge where it started.
- Why is tirzepatide more expensive?
- Tirzepatide is a dual GLP-1 and GIP agonist and is priced above semaglutide almost everywhere. Here the gap is $23 a month, which is narrower than most.
- Is EverSlim expensive compared with other GLP-1 telehealth sellers?
- EverSlim publishes a starting figure of $113/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts EverSlim below the median, toward the cheaper end. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.